⌘K

Login Start Free

Home/Filings/4/0001209191-11-012080

4//SEC Filing

Standring David 4

Accession 0001209191-11-012080

CIK 0001093649other

View on SEC.gov Company Profile

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 4:55 PM ET

Size

9.8 KB

Accession

0001209191-11-012080

Insider Transaction Report

Form 4

Period: 2011-02-22

IDENIX PHARMACEUTICALS INCIDIX

Standring David

EVP, Biology

Transactions

Award
Employee Stock Option (Right to Buy)
2011-02-22+125,000→ 125,000 total
Exercise: $3.14Exp: 2021-02-21→ Common Stock (125,000 underlying)

Footnotes (1)

[F1]The option vests in 48 equal monthly installments beginning on February 28, 2011.

Documents

2 files

Issuer

IDENIX PHARMACEUTICALS INC

CIK 0001093649

Entity typeother

Related Parties

1

filerCIK 0001428085

Filing Metadata

Form type: 4
Filed: Feb 22, 7:00 PM ET
Accepted: Feb 23, 4:55 PM ET
Size: 9.8 KB

View on SEC.gov